Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure

A double-blind, placebo-controlled, randomized crossover trial

Lee S. Marcus, Douglas Hart, Milton Packer, Madeline Yushak, Norma Medina, Robert S. Danziger, Daniel F. Heitjan, Stuart D. Katz

Research output: Contribution to journalArticle

279 Citations (Scopus)

Abstract

Background: The pharmacological effects of infusion of human brain natriuretic peptide (hBNP) in patients with severe congestive heart failure have not been characterized previously. Methods and Results: Twenty patients with severe congestive heart failure were randomized in a double-blind, placebo-controlled, crossover trial to receive incremental 90-minute infusions of hBMP (0.003, 0.01, 0.03, and 0.1 μg/kg per minute) or placebo on 2 consecutive days. At the highest completed dose of the hBNP, mean pulmonary artery pressure decreased from 38.3±1.6 to 25.9±1.7 mm Hg; mean pulmonary capillary wedge pressure decreased from 25.1±1.1 to 13.2±1.3 mm Hg; mean right atrial pressure decreased from 10.9±1 to 4.8±1.0 mm Hg: mean arterial pressure decreased from 85.2±2.0 to 74.9±1.7 mm Hg; and cardiac index increased from 2.0±0.1 to 2.5±0.1 L/min per square meter (all P<.01 versus placebo). Urine volume and urine sodium excretion increased significantly during hBNP infusion when compared with placebo infusion (90±38 versus 67±27 mL/h and 2.6±2.4 versus 1.4±1.2 mEq/h, respectively, both P<.05 versus placebo), whereas creatinine clearance and urinary potassium excretion did not change. Conclusions: Infusion of incremental doses of hBNP is associated with favorable hemodynamic and natriuretic effects in patients with severe congestive heart failure.

Original languageEnglish (US)
Pages (from-to)3184-3189
Number of pages6
JournalCirculation
Volume94
Issue number12
StatePublished - 1996

Fingerprint

Brain Natriuretic Peptide
Cross-Over Studies
Heart Failure
Hemodynamics
Placebos
Kidney
Urine
Natriuretic Agents
Pulmonary Wedge Pressure
Atrial Pressure
Pulmonary Artery
Creatinine
Potassium
Arterial Pressure
Sodium
Pharmacology
Pressure

Keywords

  • drugs
  • heart failure
  • hemodynamics
  • natriuretic peptides
  • pharmacology

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure : A double-blind, placebo-controlled, randomized crossover trial. / Marcus, Lee S.; Hart, Douglas; Packer, Milton; Yushak, Madeline; Medina, Norma; Danziger, Robert S.; Heitjan, Daniel F.; Katz, Stuart D.

In: Circulation, Vol. 94, No. 12, 1996, p. 3184-3189.

Research output: Contribution to journalArticle

Marcus, Lee S. ; Hart, Douglas ; Packer, Milton ; Yushak, Madeline ; Medina, Norma ; Danziger, Robert S. ; Heitjan, Daniel F. ; Katz, Stuart D. / Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure : A double-blind, placebo-controlled, randomized crossover trial. In: Circulation. 1996 ; Vol. 94, No. 12. pp. 3184-3189.
@article{91f02ab31f084ff8ba54079c61f14181,
title = "Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: A double-blind, placebo-controlled, randomized crossover trial",
abstract = "Background: The pharmacological effects of infusion of human brain natriuretic peptide (hBNP) in patients with severe congestive heart failure have not been characterized previously. Methods and Results: Twenty patients with severe congestive heart failure were randomized in a double-blind, placebo-controlled, crossover trial to receive incremental 90-minute infusions of hBMP (0.003, 0.01, 0.03, and 0.1 μg/kg per minute) or placebo on 2 consecutive days. At the highest completed dose of the hBNP, mean pulmonary artery pressure decreased from 38.3±1.6 to 25.9±1.7 mm Hg; mean pulmonary capillary wedge pressure decreased from 25.1±1.1 to 13.2±1.3 mm Hg; mean right atrial pressure decreased from 10.9±1 to 4.8±1.0 mm Hg: mean arterial pressure decreased from 85.2±2.0 to 74.9±1.7 mm Hg; and cardiac index increased from 2.0±0.1 to 2.5±0.1 L/min per square meter (all P<.01 versus placebo). Urine volume and urine sodium excretion increased significantly during hBNP infusion when compared with placebo infusion (90±38 versus 67±27 mL/h and 2.6±2.4 versus 1.4±1.2 mEq/h, respectively, both P<.05 versus placebo), whereas creatinine clearance and urinary potassium excretion did not change. Conclusions: Infusion of incremental doses of hBNP is associated with favorable hemodynamic and natriuretic effects in patients with severe congestive heart failure.",
keywords = "drugs, heart failure, hemodynamics, natriuretic peptides, pharmacology",
author = "Marcus, {Lee S.} and Douglas Hart and Milton Packer and Madeline Yushak and Norma Medina and Danziger, {Robert S.} and Heitjan, {Daniel F.} and Katz, {Stuart D.}",
year = "1996",
language = "English (US)",
volume = "94",
pages = "3184--3189",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure

T2 - A double-blind, placebo-controlled, randomized crossover trial

AU - Marcus, Lee S.

AU - Hart, Douglas

AU - Packer, Milton

AU - Yushak, Madeline

AU - Medina, Norma

AU - Danziger, Robert S.

AU - Heitjan, Daniel F.

AU - Katz, Stuart D.

PY - 1996

Y1 - 1996

N2 - Background: The pharmacological effects of infusion of human brain natriuretic peptide (hBNP) in patients with severe congestive heart failure have not been characterized previously. Methods and Results: Twenty patients with severe congestive heart failure were randomized in a double-blind, placebo-controlled, crossover trial to receive incremental 90-minute infusions of hBMP (0.003, 0.01, 0.03, and 0.1 μg/kg per minute) or placebo on 2 consecutive days. At the highest completed dose of the hBNP, mean pulmonary artery pressure decreased from 38.3±1.6 to 25.9±1.7 mm Hg; mean pulmonary capillary wedge pressure decreased from 25.1±1.1 to 13.2±1.3 mm Hg; mean right atrial pressure decreased from 10.9±1 to 4.8±1.0 mm Hg: mean arterial pressure decreased from 85.2±2.0 to 74.9±1.7 mm Hg; and cardiac index increased from 2.0±0.1 to 2.5±0.1 L/min per square meter (all P<.01 versus placebo). Urine volume and urine sodium excretion increased significantly during hBNP infusion when compared with placebo infusion (90±38 versus 67±27 mL/h and 2.6±2.4 versus 1.4±1.2 mEq/h, respectively, both P<.05 versus placebo), whereas creatinine clearance and urinary potassium excretion did not change. Conclusions: Infusion of incremental doses of hBNP is associated with favorable hemodynamic and natriuretic effects in patients with severe congestive heart failure.

AB - Background: The pharmacological effects of infusion of human brain natriuretic peptide (hBNP) in patients with severe congestive heart failure have not been characterized previously. Methods and Results: Twenty patients with severe congestive heart failure were randomized in a double-blind, placebo-controlled, crossover trial to receive incremental 90-minute infusions of hBMP (0.003, 0.01, 0.03, and 0.1 μg/kg per minute) or placebo on 2 consecutive days. At the highest completed dose of the hBNP, mean pulmonary artery pressure decreased from 38.3±1.6 to 25.9±1.7 mm Hg; mean pulmonary capillary wedge pressure decreased from 25.1±1.1 to 13.2±1.3 mm Hg; mean right atrial pressure decreased from 10.9±1 to 4.8±1.0 mm Hg: mean arterial pressure decreased from 85.2±2.0 to 74.9±1.7 mm Hg; and cardiac index increased from 2.0±0.1 to 2.5±0.1 L/min per square meter (all P<.01 versus placebo). Urine volume and urine sodium excretion increased significantly during hBNP infusion when compared with placebo infusion (90±38 versus 67±27 mL/h and 2.6±2.4 versus 1.4±1.2 mEq/h, respectively, both P<.05 versus placebo), whereas creatinine clearance and urinary potassium excretion did not change. Conclusions: Infusion of incremental doses of hBNP is associated with favorable hemodynamic and natriuretic effects in patients with severe congestive heart failure.

KW - drugs

KW - heart failure

KW - hemodynamics

KW - natriuretic peptides

KW - pharmacology

UR - http://www.scopus.com/inward/record.url?scp=0030481630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030481630&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 3184

EP - 3189

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 12

ER -